OneMedNet Reports 30% Revenue Drop, Increased Losses, and Critical Going Concern Warning in Q1

summarizeSummary

OneMedNet reported a 30% revenue decrease and higher net losses in Q1 2026, alongside a critical going concern warning, ongoing dilutive financing, and a reiterated Nasdaq delisting threat.

check_boxKey Events

• Significant Financial Deterioration

  Total revenue for Q1 2026 plummeted 30% year-over-year to $96,000, while net loss increased to $2.5 million from $1.9 million in Q1 2025.

• Critical Going Concern Warning

  The company explicitly states its cash balance of $0.2 million is not adequate to fund operations for at least 12 months, raising substantial doubt about its ability to continue as a going concern.

• Ongoing Dilutive Financing

  OneMedNet raised $0.5 million in Q1 2026 through a Standby Equity Purchase Agreement (SEPA) and a related party subscription. Subsequently, in April 2026, it issued an additional 1.4 million shares for $1.2 million to related parties, including an officer, at prices between $0.83 and $0.89 per share.

• Nasdaq Delisting Threat Reiterated

  The filing reiterates the April 14, 2026 notice from Nasdaq regarding non-compliance with the $1.00 minimum bid price rule, with a compliance deadline of October 12, 2026.

auto_awesomeAnalysis

OneMedNet's Q1 2026 results reveal a significant deterioration in its financial health, marked by a substantial revenue decline and increased net losses. The company explicitly states its cash balance is insufficient to fund operations for the next 12 months, raising substantial doubt about its ability to continue as a going concern. This dire financial situation necessitates ongoing dilutive financing, including recent share issuances to related parties at prices below the Nasdaq minimum bid. The company also reiterates its non-compliance with Nasdaq's minimum bid price rule and persistent material weaknesses in internal controls, compounding the severe operational and financial challenges.